RESUMO
Chlorhexidine is one of the most widely used biocides in health and agricultural settings as well as in the modern food industry. It is a cationic biocide of the biguanide class. Details of its mechanism of action are largely unknown. The frequent use of chlorhexidine has been questioned recently, amidst concerns that an overuse of this compound may select for bacteria displaying an altered susceptibility to antimicrobials, including clinically important anti-bacterial agents. We generated a Salmonella enterica serovar Typhimurium isolate (ST24(CHX)) that exhibited a high-level tolerant phenotype to chlorhexidine, following several rounds of in vitro selection, using sub-lethal concentrations of the biocide. This mutant showed altered suceptibility to a panel of clinically important antimicrobial compounds. Here we describe a genomic, transcriptomic, proteomic, and phenotypic analysis of the chlorhexidine tolerant S. Typhimurium compared with its isogenic sensitive progenitor. Results from this study describe a chlorhexidine defense network that functions in both the reference chlorhexidine sensitive isolate and the tolerant mutant. The defense network involved multiple cell targets including those associated with the synthesis and modification of the cell wall, the SOS response, virulence, and a shift in cellular metabolism toward anoxic pathways, some of which were regulated by CreB and Fur. In addition, results indicated that chlorhexidine tolerance was associated with more extensive modifications of the same cellular processes involved in this proposed network, as well as a divergent defense response involving the up-regulation of additional targets such as the flagellar apparatus and an altered cellular phosphate metabolism. These data show that sub-lethal concentrations of chlorhexidine induce distinct changes in exposed Salmonella, and our findings provide insights into the mechanisms of action and tolerance to this biocidal agent.
RESUMO
Triclosan is an active agent that is commonly found in biocide formulations which are used by the food industry to control microbial contamination. The aim of this study was to use microarray analysis to compare gene expression between a triclosan-susceptible Escherichia coli O157:H19 isolate (minimum inhibitory concentration [MIC] 6.25 µg/ml) and its in vitro generated triclosan-tolerant mutant (MIC >8,000 µg/ml). Gene expression profiling was performed on the wild-type and mutant isogenic pairs after 30 min exposure to the parent MIC for triclosan and an untreated control. Microarray analysis was carried out using the Affymetrix GeneChip E. coli Genome 2.0 Array, and differential expression of genes was analyzed using the pumaDE method in Bioconductor R software. Wild-type gene expression was found to be significantly different from the triclosan-tolerant mutant for a large number of genes, even in the absence of triclosan exposure. Significant differences were observed in the expression of a number of pathway genes involved in metabolism, transport, and chemotaxis. In particular, gene expression in the triclosan-tolerant mutant was highly up-regulated for 33 of 38 genes belonging to the flagellar assembly pathway. The presence of extended flagella in the mutant isolate was confirmed visually by transmission electron microscopy, although no significant difference was observed in the motility of the parent and mutant at low levels of triclosan. Data from this study show that at a transcriptomic level, a triclosan-tolerant E. coli O157:H19 mutant is significantly different from the wild-type strain in a number of different pathways, providing an increased understanding of triclosan tolerance.